K. Rave et al., INTRAMUSCULAR VERSUS SUBCUTANEOUS INJECTION OF SOLUBLE AND LISPRO INSULIN - COMPARISON OF METABOLIC EFFECTS IN HEALTHY-SUBJECTS, Diabetic medicine, 15(9), 1998, pp. 747-751
The aim of this study was to compare the glucodynamic effects of solub
le insulin and the rapid acting insulin analogue insulin lispro after
subcutaneous (s.c.) and intramuscular (i.m.) injection. Twelve healthy
male volunteers (age 26.8 +/- 1.7 years, BMI 23.2 +/- 2.3 kg m(-2); m
ean +/- SD) participated in this single-centre, open-labelled, euglyca
emic glucose clamp study on four different days. Soluble insulin or in
sulin lispro (0.2 U kg(-1)) were injected s.c. or i.m. into the thigh
by syringe. The glucodynamic effects were assessed by registering the
glucose infusion rates necessary to maintain blood glucose at 5.0 mmol
l(-1) for the subsequent 420 min. Intramuscular injection of soluble
insulin led to an earlier peak of metabolic action when compared to s.
c. administered soluble insulin (t(max) 138 +/- 29 vs 179 +/- 34 min;
p < 0.05). The maximal metabolic effect and metabolic activity during
the first 2 h after i.m. and s.c. injection of soluble insulin were co
mparable (GIR(max) 9.7 +/- 2.3 vs 7.8 +/- 2.3 mg kg(-1) min(-1); n.s.,
AUC(0-120) min 0.60 +/- 0.18 vs 0.50 +/- 0.15 g kg(-1) 120 min; n.s.)
. Subcutaneous administration of insulin lispro led to a metabolic eff
ect resembling that induced by i.m. application of soluble insulin (t(
max) 116 +/- 26 vs 138 +/- 29 min; n.s., GIR(max) 11.1 +/- 2.3 mg vs 9
.7 +/- mg kg(-1) min(-1); n.s.). However, the overall metabolic respon
se during the first 2 h after injection was higher with s.c. insulin l
ispro (AUC(0-120) (min) 0.81 +/- 0.26 vs 0.60 +/- 0.18 g kg(-1) 120 mi
n; p < 0.05). The glucodynamic activity of i.m. applied insulin lispro
was comparable to that of lispro s.c.. Following i.m. injection of so
luble insulin, the metabolic activity peaked more rapidly than with s.
c. administration. In contrast, the metabolic effect of insulin lispro
was similar with either route. The time-action profile of i.m. inject
ed soluble insulin lies between that of s.c. applied soluble insulin a
nd insulin lispro. (C) 1998 John Wiley & Sons, Ltd.